IDEAYA Biosciences (IDYA) Stock Research

IDEAYA Biosciences

· IDYA

Dashboard

Financials

Ratios

Valuation

Statistics

3.653 B

+1.48%

Monday

Ideaya Biosciences appoints Michael White as president, R&D

IDYA

Sep 28, 6:01 AM

Over a week ago

Ideaya Biosciences price target raised by $3 at Guggenheim, here's why

IDYA

Sep 9, 7:22 AM

Ideaya Biosciences doses first patient in OptimUM-11 trial

IDYA

Sep 9, 6:02 AM

Ideaya Biosciences announces Type C meeting with FDA for IDE849 trial design

Aug 31, 6:08 AM

Ideaya Biosciences enters IDE892 collaboration with Genentech

Aug 19, 6:05 AM

Ideaya Biosciences price target lowered by $3 at Citizens, here's why

IDYA

Aug 6, 3:27 PM

Ideaya Biosciences price target lowered by $4 at Truist, here's why

IDYA

Aug 5, 8:46 AM

Ideaya Biosciences price target raised by $2 at Wedbush, here's why

IDYA

Aug 5, 7:56 AM

Ideaya Biosciences reports Q2 EPS ($1.22), consensus ($1.05)

IDYA

Aug 4, 7:32 AM

Ideaya Biosciences initiates monotherapy expansion in IDE892 trial

IDYA

Jul 27, 6:05 AM

Ideaya Biosciences price target lowered by $2 at Truist, here's why

IDYA

Jul 7, 9:14 AM

Ideaya Biosciences price target lowered by $5 at RBC Capital, here's why

IDYA

Jul 7, 7:30 AM

Ideaya Biosciences elects CEO Yujiro Hata as chairman

IDYA

Jun 17, 6:34 AM

Ideaya Biosciences enrolls first patient in IDE892 trial

IDYA

Jun 15, 6:02 AM

Ideaya Biosciences 5.56M share Spot Secondary priced at $27.00

IDYA

Jun 9, 6:12 AM

Closing Bell Movers: Vail Resorts down 4% as earnings miss estimates

Jun 8, 7:13 PM

Ideaya Biosciences $300M Spot Secondary re-offered at $27.00

IDYA

Jun 8, 4:07 PM

Ideaya Biosciences announces $300M common stock offering

IDYA

Jun 8, 4:02 PM

Ideaya Biosciences announces IDE892 collaboration with Roche

Jun 3, 6:03 AM

Ideaya Biosciences, Servier present data from Phase 2/3 OptimUM-02 trial

IDYA

Jun 1, 11:09 AM

Ideaya Biosciences management to meet with Cantor

IDYA

May 26, 4:53 PM

Ideaya Biosciences price target lowered by $2 at Mizuho

IDYA

May 7, 7:15 AM

Ideaya Biosciences files automatic mixed securities shelf

IDYA

May 5, 4:29 PM

Ideaya Biosciences reports Q1 EPS ($1.11), consensus (98c)

IDYA

May 5, 6:22 AM

Charts